This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This core will serve three functions. First, it will develop nanoscale materials for drug delivery for each of projects. This will include new nanocarriers for drug, protein and nucleic acids delivery and include catalase nanozymes (Project 1) and copper-zinc superoxide dismutase nanozymes (Project 2), paclitaxel polymeric micelles (Project 3), and siRNA nanocarriers (Project 4). Second, the core will integrate resources of the nanotechnology laboratories for a comprehensive and in-depth characterization of the nanomaterials. The combined characterization techniques include: static light scattering;dynamic light scattering;zeta-potential measurements;atomic force microscopy;transmission electron microscopy;and fluorescence spectroscopy. Third, the core will evaluate safety of all new synthesized nanomaterials using respective cell lines and animal models, and will provide all investigators with controlled and standardized materials for biological use.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
5P20RR021937-02
Application #
7960474
Study Section
Special Emphasis Panel (ZRR1-RI-2 (01))
Project Start
2009-07-01
Project End
2010-06-30
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
2
Fiscal Year
2009
Total Cost
$184,638
Indirect Cost
Name
University of Nebraska Medical Center
Department
Other Basic Sciences
Type
Schools of Pharmacy
DUNS #
168559177
City
Omaha
State
NE
Country
United States
Zip Code
68198
Ambardekar, Vishakha V; Wakaskar, Rajesh R; Ye, Zhen et al. (2018) Complexation of Chol-DsiRNA in place of Chol-siRNA greatly increases the duration of mRNA suppression by polyplexes of PLL(30)-PEG(5K) in primary murine syngeneic breast tumors after i.v. administration. Int J Pharm 543:130-138
Gaymalov, Zagit; Kabanov, Alexander (2017) RECOPE: How to succeed in bringing ideas from academia to market without compromising ingenuity. Nanomedicine 13:795-800
Karuturi, Bala V K; Tallapaka, Shailendra B; Yeapuri, Pravin et al. (2017) Encapsulation of an EP67-Conjugated CTL Peptide Vaccine in Nanoscale Biodegradable Particles Increases the Efficacy of Respiratory Immunization and Affects the Magnitude and Memory Subsets of Vaccine-Generated Mucosal and Systemic CD8+T Cells in a Diamete Mol Pharm 14:1469-1481
Mahajan, Vivek; Gaymalov, Zagit; Alakhova, Daria et al. (2016) Data on macrophage mediated muscle transfection upon delivery of naked plasmid DNA with block copolymers. Data Brief 7:1269-82
Kim, Myung Soo; Haney, Matthew J; Zhao, Yuling et al. (2016) Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomedicine 12:655-664
Sharma, Bhawna; Nannuru, Kalyan C; Varney, Michelle L et al. (2015) Host Cxcr2-dependent regulation of mammary tumor growth and metastasis. Clin Exp Metastasis 32:65-72
Zhu, Yu; Li, Jing; Kanvinde, Shrey et al. (2015) Self-immolative polycations as gene delivery vectors and prodrugs targeting polyamine metabolism in cancer. Mol Pharm 12:332-41
Macha, M A; Rachagani, S; Pai, P et al. (2015) MUC4 regulates cellular senescence in head and neck squamous cell carcinoma through p16/Rb pathway. Oncogene 34:1698-708
Haney, Matthew J; Klyachko, Natalia L; Zhao, Yuling et al. (2015) Exosomes as drug delivery vehicles for Parkinson's disease therapy. J Control Release 207:18-30
Karuturi, Bala Vamsi K; Tallapaka, Shailendra B; Phillips, Joy A et al. (2015) Preliminary evidence that the novel host-derived immunostimulant EP67 can act as a mucosal adjuvant. Clin Immunol 161:251-9

Showing the most recent 10 out of 78 publications